Hiroki Yano

Specific Recruitment of CC Chemokine Receptor 4–Positive Regulatory T Cells in Hodgkin Lymphoma Fosters Immune Privilege

Takashi Ishida, Toshihiko Ishii, Atsushi Inagaki et al. · Cancer Research · 2006 · 289 citations · Full text

Life Sciences, Immunology, Oncology +17

Defucosylated Humanized Anti-CCR4 Monoclonal Antibody KW-0761 as a Novel Immunotherapeutic Agent for Adult T-cell Leukemia/Lymphoma

Toshihiko Ishii, Takashi Ishida, Atae Utsunomiya et al. · Clinical Cancer Research · 2010 · 243 citations

Life Sciences, Immunology, Oncology +15

N,N-Dimethylformamide-stabilized gold nanoclusters as a catalyst for the reduction of 4-nitrophenol

Hiroko Yamamoto, Hiroki Yano, Haruki Kouchi et al. · Nanoscale · 2012 · 211 citations

Natural Sciences, Chemical Engineering, Chemistry +17

Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse model

Asahi Ito, Takashi Ishida, Hiroki Yano et al. · Cancer Immunology Immunotherapy · 2008 · 127 citations · Full text

Life Sciences, Immunology, Oncology +16

Pituitary-Directed Leukemia Inhibitory Factor Transgene Causes Cushing’s Syndrome: Neuro-Immune-Endocrine Modulation of Pituitary Development

Hiroki Yano, Carol Readhead, Masahiro Nakashima et al. · Molecular Endocrinology · 1998 · 103 citations

Medicine, Endocrinology, Molecular Genetics +17